Prostaglandins and the Hypercalcemia of Cancer
- 26 July 1973
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 289 (4) , 214-215
- https://doi.org/10.1056/nejm197307262890412
Abstract
Since prostaglandins are the glamour compounds of the 70's and cancer has been designated as the target for medical research in this decade, their conjunction seemed inevitable. It is surprising, nevertheless, that a meeting should have occurred in the generally neglected field of the hypercalcemia of cancer. Hypercalcemia is a common complication of many neoplasms, some of which show direct bone involvement whereas others do not. In either case, we usually do not know the mechanism of the hypercalcemia. Only a few tumors have been shown to secrete immunoreactive parathyroid hormone. In this issue of the Journal Powell and his . . .Keywords
This publication has 5 references indexed in Scilit:
- Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcomaProstaglandins, 1973
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972
- Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood LeukocytesScience, 1972
- Prostaglandins: Stimulation of Bone Resorption in Tissue CultureEndocrinology, 1970
- The Effect of Parathyroid Hormone on the Concentration of Adenosine 3',5'-Monophosphate in Skeletal Tissue in VitroJournal of Biological Chemistry, 1970